Outsourcing STREAM

  1. M Lab™ Collaboration Centers Video 9/1/2022

    M Lab™ Collaboration Centers is a network comprised of scientific experts, innovative technologies, and flexible non-GMP facilities where you can troubleshoot your process, identify efficiencies, and adopt innovative techniques.

  2. Factors Which Impact mAb Process Scale-Up 9/7/2021

    Thinking about your mAb scale-up processes early on can help avoid common pitfalls. Cytiva’s Fast Trak scientists discuss factors that can influence a successful scale-up outcome.

  3. Increase The Titer Of A Difficult To Express Molecule 12/11/2019

    What happens if you have a promising molecule but can’t engineer a cell line to deliver the titer needed to support clinical development?  A low process titer may render the molecule, such as an antibody, too costly to manufacture and unsuitable for continued investment. Learn how our client achieved a nearly 4-fold titer increase.

  4. Explore The M Lab Collaboration Center In Burlington MA 9/19/2022

    Our global network of scientific experts, innovative technologies, and non-GMP facilities, empower drug developers of all sizes to achieve manufacturing excellence and innovation through collaborative exploration and learning. Explore 1 of our 8 global facilities today.

  5. Discovering A Unique Multimillion Euro Nanotechnology Facility 10/25/2024

    Dr. David Rowe, Head of Manufacturing at Nanoform, provides an overview of Nanoform's manufacturing capabilities and introduces a new, state-of-the-art nanotechnology facility.

  6. Reduce The Level Of Host Cell Protein In The Bioreactor Harvest 12/11/2019

    Host cell proteins (HCPs) are an inevitable byproduct of biologics manufacturing and can have an impact on product quality and efficacy as well as patient safety. Processes designed to remove HCPs from the bioreactor harvest must not only be successful in achieving acceptable limits, but also be scalable. Learn how we helped our client reduce the level of HCPs in the bioreactor harvest prior to a production run to supply drug substance for a scheduled Phase 1 clinical trial in a very tight timeline.

  7. Thermo Fisher Scientific Customer Testimonial - Libbs 9/20/2018

    An overview of Libbs product portfolio and how they benefit from Thermo Fisher Scientific services.

  8. Commercial Readiness with Orca Bio's Dan Kirby 9/14/2023

    Orca Bio's Dan Kirby has played a hand in prepping more than a few approved biologic therapeutic candidates for commercialization. Equally important, he knows firsthand what makes or breaks post-approval commercial efforts, having played virtually every role there is to play in drug sales and marketing.

  9. Building LEO Pharma's U.S. Presence with Brian Hilberdink 8/23/2023

    In many respects, bringing an established foreign biopharma company to the U.S. market is not unlike starting one up from scratch. In other respects, it's even harder. The job's not for the faint of heart, which might be why the Danish company LEO Pharma tapped veteran biopharma leader Brian Hilberdink to lead its U.S. operations.